Wordt geladen...
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
“Functional cure” is being pursued as the ultimate endpoint of antiviral treatment in chronic hepatitis B (CHB), which is characterized by loss of HBsAg whether or not anti-HBs antibodies are present. “Functional cure” can be achieved in <10% of CHB patients with currently available therapeutic a...
Bewaard in:
| Gepubliceerd in: | Front Immunol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7018702/ https://ncbi.nlm.nih.gov/pubmed/32117201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03127 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|